Eidelman Virant Capital - BIOSCRIP INC ownership

BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 96 filers reported holding BIOSCRIP INC in Q2 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.5%.

Quarter-by-quarter ownership
Eidelman Virant Capital ownership history of BIOSCRIP INC
ValueSharesWeighting
Q2 2017$67,000
-71.8%
25,000
-82.1%
0.04%
-76.2%
Q1 2017$238,000
+4.4%
140,000
-36.4%
0.16%
+26.2%
Q4 2016$228,000
-80.3%
220,000
-45.0%
0.13%
-81.7%
Q3 2016$1,156,000
+7.9%
400,000
+852.4%
0.71%
+8.0%
Q2 2016$1,071,000
-99.8%
42,000
-82.5%
0.66%
+100.9%
Q1 2016$484,800,000
+184938.2%
240,000
+60.0%
0.33%
+108.9%
Q4 2015$262,000150,0000.16%
Other shareholders
BIOSCRIP INC shareholders Q2 2017
NameSharesValueWeighting ↓
KEANE CAPITAL MANAGEMENT INC 894,943$3,965,0003.86%
DSC Advisors, L.P. 1,200,000$5,316,0002.82%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 2,208,710$9,785,0001.96%
ARDSLEY ADVISORY PARTNERS LP 3,010,000$13,335,0001.85%
First Washington CORP 709,600$3,144,0001.82%
WYNNEFIELD CAPITAL INC 505,500$2,239,0000.99%
Camber Capital Management LP 3,000,000$13,290,0000.95%
MARATHON CAPITAL MANAGEMENT 478,800$2,121,0000.94%
KING INVESTMENT ADVISORS INC/TX 315,040$1,402,0000.67%
THB ASSET MANAGEMENT 2,082,955$9,227,0000.64%
View complete list of BIOSCRIP INC shareholders